We are live on ! Find out more
LABU icon

Direxion Daily S&P Biotech Bull 3X ETF
LABU

47 hedge funds and large institutions have $34.5M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more call options, than puts

Call options by funds: $69.2M | Put options by funds: $18M

250% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 6

47% more funds holding

Funds holding: 32 → 47 (+15)

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

0.03% less ownership

Funds ownership: 0.2% → 0.17% (-0.03%)

19% less capital invested

Capital invested by funds: $42.4M → $34.5M (-$7.95M)

Holders
47
Holders Change
+15
Holders Change %
+46.88%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
11
Reduced
9
Closed
6
Calls
$69.2M
Puts
$18M
Net Calls
+$51.2M
Net Calls Change
+$38M

Top Buyers

Rank Fund Capital Flow
1
Simplex Trading
Simplex Trading
Illinois
+$9.06M
2
AIP
Ahrens Investment Partners
Louisiana
+$3.87M
3
HF
HRT Financial
New York
+$3.46M
4
LJAC
L.J. Altfest & Co
New York
+$1.74M
5
Millennium Management
Millennium Management
New York
+$985K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$2.85M
2
TCM
Traynor Capital Management
Pennsylvania
-$2.39M
3
Jane Street
Jane Street
New York
-$2.36M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.44M
5
Wolverine Trading
Wolverine Trading
Illinois
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
HJMC
26
Hellman Jordan Management Company
Massachusetts
$135K -$319K -1,872 -65%
EW
27
Evoke Wealth
California
$135K – – –
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$125K -$599K -3,514 -79%
PWP
29
Pursue Wealth Partners
California
$94K +$119K +700 New
Jane Street
30
Jane Street
New York
$83K -$2.36M -13,860 -96%
XSC
31
X-Square Capital
Puerto Rico
$83K -$6.81K -40 -6%
Vontobel Holding
32
Vontobel Holding
Switzerland
$80K +$101K +595 New
UBS Group
33
UBS Group
Switzerland
$75K -$19.8K -116 -17%
Goldman Sachs
34
Goldman Sachs
New York
$74K +$93.7K +550 New
TRCT
35
Tower Research Capital (TRC)
New York
$43K +$40.7K +239 +288%
SWM
36
Spire Wealth Management
Virginia
$40K +$22.5K +132 +79%
Osaic Holdings
37
Osaic Holdings
Arizona
$34K +$16.2K +95 +59%
PVH
38
Psagot Value Holdings
Israel
$13K +$17K +100 New
Barclays
39
Barclays
United Kingdom
$9K – – –
TCM
40
Tradewinds Capital Management
Washington
$4K +$4.43K +26 New
QC
41
Quent Capital
New York
$4K +$5.11K +30 New
US Bancorp
42
US Bancorp
Minnesota
$2K -$9.37K -55 -79%
TWA
43
TCI Wealth Advisors
Arizona
$2K +$1.53K +9 +180%
HWMA
44
Heritage Wealth Management (Arizona)
Arizona
$1.96K +$2.56K +15 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$1K – – –
Renaissance Technologies
46
Renaissance Technologies
New York
– -$2.85M -9,100 Closed
TCM
47
Traynor Capital Management
Pennsylvania
– -$2.39M -7,615 Closed
Wolverine Trading
48
Wolverine Trading
Illinois
– -$1.08M -6,359 Closed
TC
49
Titleist Capital
Texas
– -$274K -875 Closed
CCS
50
Crosspoint Capital Strategies
California
– -$8K -25 Closed
1
2
3

LABU Hedge Fund Activity: Q2 2022 in Review

47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q2 2022, worth a combined $34.5M — down 19% from $42.4M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new LABU positions and 6 closed out — a net gain of 15 holders — while 11 added to existing stakes and 9 trimmed.

The largest buyer was Simplex Trading, adding an estimated $9.06M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.85M sold.

  • 47 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q2 2022, up from 32 in Q1 2022.
  • Funds reported $34.5M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q2 2022, down 19% quarter-over-quarter.
  • 21 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q2 2022 and 6 closed out, a net change of +15 holders.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q2 2022 was Simplex Trading, an estimated $9.06M added.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q2 2022 was Renaissance Technologies, an estimated $2.85M sold.

Based on aggregated 13F filings for Q2 2022.